DrugPatentWatch Database Preview
Drugs in Development Information for PQR309
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug PQR309?
PQR309 is an investigational drug.
There have been 9 clinical trials for PQR309.
The most recent clinical trial was a Phase 1 trial, which was initiated on June 15th 2017.
The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Glioblastoma. The leading clinical trial sponsors are PIQUR Therapeutics AG, University Hospital, Basel, Switzerland, and Roswell Park Cancer Institute.
There are three US patents protecting this investigational drug and forty-four international patents.
Summary for PQR309
| US Patents | 3 |
| International Patents | 44 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2017-06-15) |
| Vendors | 27 |
Recent Clinical Trials for PQR309
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating Safety and Efficacy of Bimiralisib in Patients With Head and Neck Squameous Cell Carcinoma | PIQUR Therapeutics AG | Phase 2 |
| PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma | PIQUR Therapeutics AG | Phase 2 |
| Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients | Charite University, Berlin, Germany | Phase 2 |
Clinical Trial Summary for PQR309
Top disease conditions for PQR309
Top clinical trial sponsors for PQR309
US Patents for PQR309
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PQR309 | Start Trial | Manufacturing process for triazine, pyrimidine and pyridine derivatives | UNIVERSITAET BASEL (Basel, CH) PIQUR THERAPEUTICS AG (Basel, CH) | Start Trial |
| PQR309 | Start Trial | Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes | University of Basel (Basel, CH) | Start Trial |
| PQR309 | Start Trial | Triazine compounds | Sphaera Pharma PTE. Ltd. (Singapore, SG) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PQR309
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PQR309 | Australia | 2015250994 | 2034-04-22 | Start Trial |
| PQR309 | Brazil | 112016023811 | 2034-04-22 | Start Trial |
| PQR309 | Canada | 2944697 | 2034-04-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
